Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gyorgy Snell

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|June 9, 2020
Structural and functional analysis of a potent sarbecovirus neutralizing antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature|May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature Communications|March 2, 2026
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza virusesSaya Moriyama, Julia di Iulio, Fabrizia Zatta, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Journal of Hepatology|July 17, 2023
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Science (New York, N.Y.)|January 6, 2022
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Science (New York, N.Y.)|July 20, 2022
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodiesJun Siong Low, Josipa Jerak, M Alejandra Tortorici, et al.
Science (New York, N.Y.)|July 20, 2022
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccinesJohn E Bowen, Amin Addetia, Ha V Dang, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|June 9, 2020
Structural and functional analysis of a potent sarbecovirus neutralizing antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature|May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature Communications|March 2, 2026
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza virusesSaya Moriyama, Julia di Iulio, Fabrizia Zatta, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Journal of Hepatology|July 17, 2023
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Science (New York, N.Y.)|January 6, 2022
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Science (New York, N.Y.)|July 20, 2022
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodiesJun Siong Low, Josipa Jerak, M Alejandra Tortorici, et al.
Science (New York, N.Y.)|July 20, 2022
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccinesJohn E Bowen, Amin Addetia, Ha V Dang, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Pageof 7